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SUMMARY  
________________________________________________________________________ 
     
Osteomyelitis is an infection of the bone and successful treatment involves the removal 
of the effected bone and the tissue by a surgical procedure and implantation of a 
composition of Gentamicin that gives sustained release of the drug for a period of about 
6-8 weeks. Systemic administration of Gentamicin has shown that high dosages are 
required in order to achieve sufficient concentration at the local area. Local 
administration and sustained release is being currently achieved by Gentamicin-loaded 
poly methyl methacrylate (PMMA) beads. However, PMMA is not biodegradable and a 
second surgical procedure is required in order to remove the PMMA beads. Also, it was 
observed that the PMMA beads did not release all of the Gentamicin. The current study 
aims to develop a biodegradable/biocompatible composition that gives sustained release 
and hence reducing the need for a second surgery. 
 
We have started working on microspheres made by spray drying a mixture of poly 
lactide-co-glycolide solution and Gentamicin solution and the results have shown that all 
of the Gentamicin was released out in less than one day. Also, there is not much effect of 
the type of polymer in terms of copolymer ratios of PLA and PGA on the release 
characteristics. We have then worked on the possibility of compressing the microspheres 
into a disc and studied the release characteristics. The release from the discs has given a 
biphasic behavior with an initial release followed by a lag phase and a second release. 
The initial release corresponds to the release of the drug that was present in the 
microspheres, which are present near the surface when the disc was compressed. 
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Depending on the type of polymer the period of the lag phase varied. The second release 
starts when the polymer starts to degrade.  
 
With this result, we have directed our effort in order to modify the release profile by 
eliminating the lag phase. Hence a hydrophilic and biocompatible polymer poly ethylene 
glycol (PEG) was introduced before spray drying with an intension that PEG may 
migrate out of the discs as it is hydrophilic and thus making the discs porous and giving 
way for the drug to come out easily. Methylcellulose was tried for modifying the porosity 
of the discs. Also, pure microspheres made of PLGA were blended with hydroxylapatite 
and β-tricalcium phosphate and discs were made and the in vitro release was studied. In 
all the cases it was observed that only the initial release was increased with increased 
addition of another material to PLGA. The lag phase was reduced in time, but still the 
profile followed a biphasic behavior.  
 
In an effort to get a composition that does not give a biphasic behavior, discs with solid 
Gentamicin were prepared. Gentamicin as solid was spray dried with the polymer and the 
resultant microparticles were compressed to obtain a disc. This procedure does not give 
uniformity of Gentamicin on the molecular level, but still can give sufficient uniformity 
in distribution that allows for the results to be reproduced. It was observed that 10% drug 
loading was optimum for Gentamicin to be used as solid in spray drying. The results 
showed that about 60 % of the drug is released in about 5-6 days and the remaining drug 
is released in about 30 days in total. Since 60% initial release might be large, a more 
hydrophobic PLGA (PLGA 85:15) was introduced anticipating lesser initial release. 
  Summary 
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However, all samples followed a similar profile and the hydrophobic-hydrophilic nature 
of the polymer did not play a major role when Gentamicin is used as solid.  
 
Samples, which gave up to 30 days release, were then used for in vivo studies on rabbit 
models. Male New Zealand rabbits were used in the study and the discs were implanted 
in the bone after drilling the bone. Study involved the blood sampling from the bone and 
the ear to check the local area concentration and systemic concentration respectively. It 
was observed that the local area concentration was relatively very large when compared 
to the systemic concentration and also the systemic concentration was negligible after one 
week. Another batch of rabbits were operated and PMMA beads were implanted. These 
beads were removed after a two-week period and them the biodegradable discs were 
implanted and similar study was performed.  
 
In the thesis the results and discussions pertaining to the above studies are presented in 
detail. Future work related to the use of discs in bacteria infected rabbits to further 
establish the efficacy of the composition and the possibility of extending the project to 
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The encapsulation efficiency and particle size of the 
microspheres prepared using three types of PLGA. 
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Table 4.2  
 
Different percentage of PEG and different molecular weight of 
PEG that was used while the microspheres were prepared. P 
represents PEG. The prefix number to P represents the 
percentage of PEG used in total weight of polymer content. 
The suffix number to P represents the molecular weight of the 
PEG used. For all samples PLGA 50:50 was used as the main 





Encapsulation efficiency for methyl cellulose-PLGA 
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represents the percentage of MC in total weight of polymers. 
For all samples PLGA 50:50 was used as the main polymer 
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Shows concentration from two batches of samples in µg/ml. 
For rabbits 1 to 3 and 4 to 5, the discs made using PLGA 85:15 
and PLGA 65:35 in the ratio 7:3 and 5:5 are implanted. 
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Table 4.6  Table 4.6 Shows concentration from two batches of 
samples in µg/ml. For rabbits 7 to 9 the discs made using 
PLGA 85:15 and PLGA 65:35 in the ratio 9:1 and for10 to 
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Figure 2.4  
 
Fluorogenic reaction of primary amine with OPA 27 
Figure 4.1 
 
The SEM of microspheres made using three types of PLGA.  
A: PLGA 50:50. B: PLGA 65:35. C: PLGA 85:15 
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Figure 4.2  
 
The release of Gentamicin from the microspheres made using 




Figure 4.3  
 
The release of Gentamicin from discs made by compressing 
PLGA microspheres (microspheres of PLGA 65:35 and PLGA 





SEM of different microparticles on the addition of PEG to 
PLGA. A: 20 % PEG. B: 15 % PEG. C: 10% PEG. D: PEG 
mol.wt 3,350. E: PEG mol.wt 1450. F: 5% PEG. G: 2% PEG. 
The mol.wt. for A, B, C, F and G is 8,000. D and E has 10% 
PEG. For all samples PLGA 50:50 was used as the main 
polymer along with PEG. 
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Figure 4.5  
 
SEM picture showing extent of degradation in PEG-PLGA 
discs. A: 2% PEG mol.wt 8,000. B: 5% PEG mol.wt 8,000. C: 
10% PEG mol.wt. 8,000. D: 10% PEG mol.wt 3,350. E:10% 
PEG mol.wt 1,450. A, B, C, D, E are after 20-day release. F: 
10% PEG mol.wt 8,000 before release. For all samples PLGA 







In vitro release from PEG-PLGA discs. Prefix represents the 
percentage of PEG and molecular weight of PEG is written as 
suffix. (K represents kilo). The sample with 35 has a higher 
mass. For all samples PLGA 50:50 was used as the main 




















In vitro release from PEG-PLGA discs. Prefix represents the 
percentage of PEG and molecular weight of PEG is written as 
suffix. (K represents kilo). The sample with 35 has a higher 
mass. For all samples PLGA 50:50 was used as the main 
polymer along with PEG. 
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Figure 4. 7 SEM picture of methyl cellulose-PLGA microparticles. A: 2% 
MC in PLGA 50:50. B; 5 % MC in PLGA 50:50 
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Figure 4. 8 
 
In vitro release from methyl cellulose-PLGA discs. MC is 
methyl cellulose and the number represents the percentage of 
MC in total weight of polymers. For all samples PLGA 50:50 





In vitro release discs made by blending β-tricalcium phosphate 
(at 60%) and microspheres. PLGA 50:50, PLGA 65:35 and 







In vitro release discs made by blending hydroxylapatite(at 
60%) and microspheres. PLGA 50:50, PLGA65:35 and PLGA 
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In vitro release from calcium phosphate and microspheres 
blended discs at 40 % and 30 % calcium phosphate with 
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SEM pictures of microparticles of high drug loading 








In vitro release of Gentamicin from high drug loaded discs. 
The effect of different theoretical drug loading (10%, 15%, 









In vitro release of Gentamicin from 10% drug loading. The 
ratio of PLGA 85:15 and PLGA 50:50 is used to study the 






An X-ray showing the extent of regeneration of bone after 






DSC data showing the amount of degradation of each 
sample in vivo. A: pure 1:1 mixture of PLGA 85:15 and 
PLGA 50:50. B: PLGA 85:15 and PLGA 50:50 at 1:1 ratio 
(sample 5:5) after 6-weeks of in vivo study showing that 
there is large scale degradation and possible migration of 
polymer. C: PLGA 85:15 and PLGA 50:50 in the ratio 7:3 
after 6-weeks of in vivo shows that some of the polymer is 
not degraded. Tb is boiling point of the residual solvent and 










A step-wise pictures to show the procedure of operation 
for the second time to remove the PMMA beads and 







A, B, C, D and E. The SEM figures showing the porosity 
when different concentrations of the polymer solutions are 











CHAPTER I  
INTRODUCTION 
 
1.1 Motivation and Objectives 
The infection that causes Osteomyelitis is generally present in another part of the body 
and spreads to the bone via the blood.  The affected bone may have been susceptible 
because of damage or trauma that is left after an accident (NIH, USA, 2002). Many 
different bacteria cause Osteomyelitis. The most common are Staphylococcus aureus, 
Staphylococcus epidermis and Pseudomonas aeruginosa.  In children, the long bones are 
usually affected. In adults, the vertebrae and the pelvis are most commonly affected. 
Bone infection can be caused by bacteria or by fungus. When the bone is infected, pus is 
produced within the bone, which may result in an abscess. The abscess then deprives the 
bone of its blood supply.  
 
Chronic Osteomyelitis results when bone tissue dies as a result of the lost blood supply. 
Chronic infection can persist intermittently for years. Risk factors are recent trauma, 
diabetes, hemodialysis and intravenous drug abuse. People who have had their spleen 
removed are also at higher risk for Osteomyelitis. The incidence of Osteomyelitis is 2 in 
10,000 people. 
 
Symptoms include pain in the bone, local swelling, redness and warmth, fever, nausea, 
general discomfort, uneasiness or ill feeling, drainage of pus through the skin in chronic 
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cases. Additional symptoms include excessive swelling, chills, low back pain, and 
swelling of the ankles, feet and legs. 
   
The objective of the treatment is to eliminate the infection and prevent the development 
of chronic infection. Intravenous antibiotics are started initially and may later be changed 
depending on culture results of samples that are taken from the patients. Some new 
antibiotics can be very effective when given orally. In chronic infection, surgical removal 
of dead bone tissue is usually necessary. The open space left by the removed bone tissue 
may be filled with bone graft or by packing material to promote the growth of new bone 
tissue. Antibiotic therapy is continued for at least 3 weeks after surgery. Infection of an 
orthopedic prosthesis may require surgical removal of the prosthesis and of the infected 
tissue surrounding the area. A new prosthesis may be implanted in the same operation or 
delayed until the infection has resolved, depending on its severity.  
 
The outcome is usually good with adequate treatment of acute Osteomyelitis. The 
prognosis is worse for chronic Osteomyelitis, even with surgery. Resistant or extensive 
chronic Osteomyelitis may result in amputation, especially in diabetics or other patients 
with poor blood circulation. Complications include reduced limb or joint infection and 
amputation.  
 
1.2 Organization of thesis 
The thesis is presented as introduction in Chapter I and background and literature review 
in Chapter II. In the second chapter, emphasis is laid on the various biomaterials and 
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properties of the bone as this study can be extended into bone and bone tissue 
regeneration. Analysis of drug is also reviewed and a procedure accepted by the British 
Pharmacopoeia is used in the study. Chapter III deals with the various methods used 
during the study. Among them, in vitro and in vivo are the important studies. The chapter 
on results and discussion is Chapter IV and the first two parts are on in vitro studies and 
the third part is on in vivo studies for better understanding. The first part of in vitro 
studies concentrates on the use of different materials and the modification of porosity of 
discs in order to achieve better release profiles. The second part is an in vitro release with 
Gentamicin as a solid. The work on in vivo rabbit models was carried at Orthopedics 
Research Center, Kaohsiung Medical University under the guidance of Dr. Yin-Chih Fu, 
an Orthopedic Surgeon.  Chapter V is the concluding chapter where the results are 
summarized and recommendations for the extension of the project into bone-tissue 
regeneration are presented. 
CHAPTER II 
BACKGROUND AND LITERATURE REVIEW 
 
A detailed understanding of the characteristics of the target tissue, the drug structure and 
action and delivery system is vital for achieving maximum therapeutic benefit. The 
essential characteristics of an ideal targeting system have been defined as the following: 
Mills et al., 1987; Davis et al., 1985.  Compatibility with the body in terms of toxicity, 
biodegradability and antigenicity, protection of the drug until it reaches its site of action, 
maintenance of the drug carrier integrity until the target is reached, avoidance of 
interaction with normal cells, an ability to traverse intervening membranes, target 
recognition and association, controlled drug release to achieve the desired therapeutic 
effect and carrier elimination from the body following drug delivery are the required 
characteristics of a drug delivery system.  
 
2.1.1 Polymeric Materials 
Polymers have found applications in every specialty area and continue to be the most 
widely used materials in health care. Polymers can be classified in several different ways 
according to their structures, the type of reactions by which they are prepared, their 
physical properties or their technological use. The earliest and most frequent application 
of textile for surgery is believed to be suture material used to close wounds. As early as 
four thousand years ago, linen was used as a suture material. Later natural fiber from the 
bark of trees, plaited horsehair, cotton and silk were also used. Due to the development of 
synthetic fibers like nylon, polyesters and polyolefins in the 1950s, synthetic fibers have 
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gradually replaced natural fibers for wound closure purposes. The significant properties 
that are studied regarding the structural and properties of polymers are (a) composition 
(b) molecular weight (c) amount of unreacted monomer in the polymer (d) morphology 
(e) crystallinity (f) configurational structure (g) additives.  
 
The methods of polymeric synthesis are divided into addition polymerization and 
condensation polymerization. The addition polymers are obtained by subjecting olefinic 
compounds to polymerization. The condensation polymers are typically formed from 
reactions of alcohols and acids to form polyesters, reactions of acids or esters with 
amines to form polyamides or reaction of alcohols or amines with isocyanates to form 
polyurethanes or polyurea respectively. Unlike condensation polymerization where small 
molecules are formed, addition polymerization involves only rearrangement of bonds. 
The backbone of addition polymers consists only of carbon-carbon bonds, whereas 
condensation polymers contain carbon-hetero atom bonds in the main chain. Siloxane 
polymers have silicon oxygen bonds in the backbone. The different manufacturing 
techniques used to make polymers are bulk, melt, solution, suspension, emulsion or 
interfacial polymerization.  
 
The structure of polymers determines their utilization in various medical domains. Their 
selection for subsequent employment in surgery, dermatology, ophthalmology, pharmacy 
etc., is mainly determined by their chemical and physical properties. The stability and 
lifetime of polymers in long-term implantation depend not only on the chemical structure 
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of materials employed but also on the conditions under which they are utilized. The same 
material may have different characteristics depending on its utilization.  
Synthetic Polymers: Biomedical polymers can be classified into elastomers and plastics. 
Elastomers are able to with stand large deformations and return to their original 
dimensions after releasing the stretching force. Plastics on the other hand are more rigid 
materials and can be classified as two type (a) thermoplastics and (b) thermosets. 
Thermoplastic polymers can be melted, reshaped and reformed. The thermosetting 
plastics cannot be remelted and reused, since the chemical reactions that have taken place 
are irreversible. The thermoplastic polymers used as biomaterials include polyolefins, 
Teflon (fluorinated hydrocarbons), poly methyl methacrylate (PMMA), poly 
hydroxyethyl methyacrylate (PHEMA, hydron), poly vinyl chloride (PVC), 
polycarbonate, nylon, polyester (Dacron) etc. An example of theromosetting plastics is 
the epoxy resin cross linked with a curing agent. A number of elastomers have been tried 
as implant materials. They are butyl rubber, chlorosulfonated polyethylene (hypalon), 
epichlorohydrin rubber (hydrin), polyurethane (biomer, pellethane, texin, tecoflex HR, 
lyca T0126), natural rubber and silicone rubber (silastic).  
 
Cross-linking of the main chains of thermoplastics is in effect similar to chain 
substitution with small molecules and lowers the melting temperature. This is due to the 
interference of the cross linking which can decrease the mobility of chains resulting in 
further retardation of the crystallization rate. However, opposite results can be obtained 
when elastomers or rubbers are cross linked. A major consideration when implanting 
plastics is the toxicity of these additives and the ease with which they may be released 
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into the surrounding tissues. Residual monomers due to incomplete polymerization and 
catalyst used for polymerization may cause irritations. For these reasons polymers to be 
used in vivo must be well characterized in order to prevent such tissue reactions.  
 
Some of the non biodegradable polymers used in the medical devices are ( Sujata VB, 
2002):   
Polyethylene- is easy to process, has excellent insulation properties, chemical resistance, 
toughness and flexibility at low temperatures-it is used for various catheters, hip joints 
and knee joints.  
Polypropylene-has excellent chemical resistance, weak permeability to water vapors, 
good transparency and surface reflection-is used as yarn for surgery and as sutures. 
Tetrafluoroethylene-chemical inertness, exceptional weathering and heat resistance, non 
adhesive, very low coefficient of friction is used for vascular and auditory prostheses, 
catheters and tubes.  
Poly vinyl chloride-has excellent resistance to abrasion, good dimensional stability, high 
chemical resistance to acids, alkalis, oils, fats, alcohols and aliphatic hydrocarbons-it is 
used to make flexible and semi-flexible tubes, catheter, inner tubes, components of 
dialysis installation and temporary blood storage.  
Polyacetals-has stiffness, fatigue endurance, resistance to creep, excellent resistance to 
action of humidity, gas and solvents-used as hard tissue replacement.  
Poly methyl methacrylate-has good transparency, good thermal properties-used in bone 
cement, intraocular lenses, contact lenses, fixation of articular prostheses and dentures. 
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Polycarbonate-is rigid and tough up to 140°C, is transparent, good electrical insulator-
used in syringes, arterial tubules and hard tissue replacement.  
Polyethylene terephthalate-transparent, good resistance to traction and tearing, resistance 
to oils, fats and many organic solvents-used in vascular, laryngeal, esophageal prostheses, 
surgical sutures, knitted vascular prostheses.  
Polyamide-very good mechanical properties, resistance to abrasion and breaking, stability 
to shock and fatigue, low friction coefficient, good thermal properties, good chemical 
resistance, permeable to gases-used as PA-6 tubes for intracardiac catheters, urethral 
sound, surgical sutures, films for package, dialysis devices components, PA 66 heart 
mirtal valves, three way valve for perfusion, hypodermic syringes.  
Polyurethane- exceptional resistance to abrasion, high resistance to breaking, very high 
elasticity modulus at compression, traction and sheering remarkable elongation to 
breaking-used as adhesive, dental materials, blood pumps, artificial heart and skin. 
Silicone rubber-good thermal stability, resistance to atmospheric and oxidative agents, 
physiological inertness-encapsulation of pacemakers, burn treatment, shunt, mammary 
prostheses, foam dressing, valve, catheter, contact lenses, membranes, maxillofacial 
implants. 
 
Another class of polymers is the hydrogels. They derive their name from their affinity for 
water and incorporation of water into their structure. The concentration of water in the 
hydrogel can significantly affect the interfacial free energy of the hydrogel as well as the 
biocompatibility. They have inherent mechanical properties and are attached to some 
tougher materials such as silicone rubber, polyurethane, or PMMA for some applications. 
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Hydrogels may be attached to conventional polymer substrates by a number of surface 
grafting techniques (Bruck, 1974; Bruck, 1977). These procedures include chemical 
initiation such as the cearic ion technique or irradiation with electrons accelerated by high 
voltages, high-energy 60 Co-gamma rays and microwave discharge. The absorption of a 
solute into the network and the controlled release of the solute into an aqueous 
environment are intimately related to the swelling properties of the network involved. 
The interest on hydrogels as biomaterials stems from a number of advantages (a) the soft 
rubbery nature of hydrogels minimizes the mechanical and frictional irritation to the 
surrounding tissues (b) these polymers may have a low or zero interfacial tension with the 
surrounding biological fluids and tissues, thereby minimizing the driving force for protein 
adsorption and cell adhesion (c) hydrogels allow the permeation and diffusion of low 
molecular weight metabolites, waste products and salts as do living tissues (Changez et 
al., 2003).  
 
Coming to the class of synthetically prepared biodegradable polymers, interest in the 
possible biodegradation of synthetic polymers has developed only in recent years and 
primarily on response to the growing problem of waste disposal of plastics. All 
biopolymers are susceptible to enzymatic degradation because the enzymatic 
polymerization reactions for their synthesis in nature have closely related counterparts for 
their enzymatic depolymerization.  This has to be considered during the fabrication of 
syntheticaly prepared biodegradable polymers. Some of the important factors affecting 
the rate of degradation of synthetic polymers in a biological environment are (a) polymer 
structure, especially hydrophilicity and the presence of functional groups in or 
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immediately on the main chain; also molecular weight (b) physical and morphological 
state of the polymer particularly whether it is crystalline or amorphous, the degree and 
form of crystallinity, the glass transition temperature (c) environmental conditions 
(temperature, pH, humidity, oxygen availability etc) (Lenz, 1993).  Biodegradable 
materials have four major applications in medicine (a) adhesives (b) the temporary 
scaffold (c) temporary barrier and (d) drug delivery matrix.  
 
In drug delivery, optimal drug delivery profiles are necessary. The problem reduces 
theoretically to being able to load a biodegradable polymer matrix with as high a 
concentration as possible and to have a matrix that degrades at a predictable rate so that 
the release of the drug into the tissues of the target organ is controlled. The matrix is a 
vehicle, which should disappear as rapidly as possible after the pharmacologically active 
agent has been delivered. In practice 20% to 25% is the upper limit for the drug loading 
and the delivery mechanism is usually a combination of matrix degradation and drug 
diffusion. Most polymers are hydrophilic and as water penetrates the matrix, the more 
hydrophilic the drug, the easier it is removed. It is preferable that the degradation 
products are inert or one of the constituents of the body.  
 
To develop and fully exploit the success described previously in delivering non-
degradable particles to specific target sites it will be necessary to use biodegradable 
microparticles that adequately mimic the physicochemical properties, size and surface 
nature of successful non-degradable systems. Consequently increasing attention is now 
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turning toward the potential applications of targeted nanoparticulate systems for drug 
delivery that are formulated from biodegradable polymers.  
 
An increasing requirement for the modulated delivery of both conventionally and 
biotechnology-generated drugs of a high molecular weight and short half-life has 
generated considerable interest in the development of biodegradable polymers and their 
formulation into drug delivery systems. The use of biodegradable polymers confers the 
inherent advantage of alleviating the need for surgical removal of the delivery system at a 
later date. However, despite extensive investigation of drug delivery systems and 
vaccines, comparatively little work has involved the formulation of carriers from these 
materials capable of achieving site-specific delivery.   
 
Biodegradable polymers used in drug delivery research may be broadly classified as of 
natural or synthetic origin. The majority of investigations into the use of natural polymers 
as drug delivery systems have concentrated on the use of proteins and polysaccharides, 
which are discussed later. The synthetic polymers are all investigated for formulation of 
controlled drug delivery systems. They may be synthesized with specific properties to 
suit particular applications.  
 
Polycaprolactone (PCL) is aliphatic polyester having a relatively slow degradation rate, 
which may be increased by copolymerization. PCL has a high permeability to many 
drugs, which consequently provides rapid release characteristics from PCL devices (Pitt 
et al., 1979) Poly ortho esters have the advantage over some materials of undergoing 
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controlled degradation. This process is important for polypeptides that have a molecular 
weight too large to be released by a diffusion mechanism. To maximize control over the 
process of drug release from polymeric matrices, surface degradation is desirable, which 
means that the rate of polymer degradation at the surface of the device is greater than the 
water penetration rate into the bulk of the polymer (Chasin et al., 1990). Consequently, 
polyanhydride polymers and copolymers have attracted considerable interest for the 
fabrication of the drug delivery systems because of the highly labile anhydride linkages 
in the polymer structure.  
 
Polyphosphazenes are a relatively new group of biodegradable polymers. Their 
degradation rates are controlled by side group modification. Also, reactive drug 
molecules can be linked to the polymer backbone. Poly malic acid and its derivatives 
form another range of biodegradable polymers that have received attention. Some 
examples are :  Aliphatic polyesters –poly glycolide, poly lactide, poly caprolactone. 
Polyanhydrides-poly bis(p-carboxyphenoxy) propane anhydride, poly 
carboxyphenoxyacetic acid, poly carboxyphenoxyvaleric acid, polyphosphazenes-
aryloxyphosphazene polymer, amino acid ester systems (Gursel et al., 2002). 
 
Polymers Selected include the most widely investigated and advanced synthesis 
polymers in terms of the available toxicological and clinical data are the linear aliphatic 
polyesters based on the hydroxyacids lactic acid and glycolic acid. Poly lactic acid 
(PLA), poly glycolic acid (PGA) and poly lactide-co-glycolide (PLGA) display important 
advantages of biocompatibility, predictability of biodegradation kinetics, ease of 
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fabrication and regulatory approval (Lewis, 1990). More importantly these polymers can 
be purchased commercially (Friess et al., 2002). They are used as resorbable sutures and 
have been investigated for bone plates, implant materials, bone graft substitutes and nerve 
graft substitutes. Some commercially available formulations made of these polymers are 
Parlodel SA, Sandoz; Zoladex, Zeneca; and Prostrap, Lederle.   
 
PLA and PGA are produced by ring opening melt condensation of the cyclic dimmers 
lactide and glycolide.  Polymerization is usually conducted over 2-6 hrs at 175°C in the 
melt in the presence of an organic catalyst such as stannous chloride or stannous octoate. 
Controlled polymerization requires a low monomer activity and low humidity. The use of 
catalysts however may be undesirable and hence several recent reports have detailed the 
synthesis of low molecular weight polymers via a direct polycondensation in the absence 
of catalyst (Yoshikawa et al., 1987). Because of an asymmetric β carbon of lactic acid D 
and L stereoisomers are formed and hence polymers exist in the D, L or racemic DL 
forms.  
 
The physical properties of PLA, PGA and PLGA polymers can be fairly well defined at 
the synthesis stage by attention to the monomer stereochemistry, co-monomer ratio, 
polymer chain linearity and the polymer molecular weight. Polymer crystallinity is 
known to be important determinant of polymer degradation, which influences the release 
profile of encapsulated proteins and peptides (Robinson et al., 1992). The crystallinity 
decreases with increasing copolymer content and 25-75% copolymers are amorphous. 
The rate of water uptake will be influential in determining the rate of polymer 
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degradation and hence drug release from targeted devices (Huang et al., 2001). The 
hydrophobic nature of the polymers also varies with the structural composition. PLA is 
more hydrophobic than PGA because of the methyl side group in the chain structure 
(Zhang et al., 1994). The block or random structure is also important in determining the 
hydrophobicity of polymers.  
 
Biocompatibility of PLA and PLGA implants is good and adverse tissue responses are 
mild with no abnormalities. In some cases a mild inflammatory response is observed and 
it disappears as degradation progresses. However, no adverse immunological or 
toxicological effects are reported. Biodegradation of the aliphatic polyesters proceeds by 
homogenous or bulk degradation due to the hydrolytic deesterification to their constituent 
monomers. The lactic and glycolic acids are bioresorbable metabolites that are 
subsequently taken by the endogenous pool of the body and eliminated by Krebs cycle as 
carbon dioxide and in urine (Lewis, 1990).  It has been also observed that the lower 
molecular weight polymers degrade faster and hence minimizing the possible side effects.  
 
2.1.2 Materials in Orthopedic implants 
The types of ceramic materials used in biomedical applications may be divided into three 
types according to their chemical reactivity with the environment (a) completely 
resorbable (b) surface reactive (c) nearly inert. Nearly inert ceramics like alumina and 
carbons show little chemical reactivity even after thousands of hours of exposure to the 
physiological pH and therefore show minimal interfacial bonds with living tissues. The 
fibrous capsule adjacent to alumina implants is only a few cells thick. Surface reactive 
                                                                    Chapter II: Background and Literature Review 
________________________________________________________________________ 
 15
bioglass ceramics exhibit an intermediate behavior(Park 1979; Park 1984). In these 
ceramics, surface provides bonding sites for the proteinaceous constituents of soft tissue 
and cell membranes, producing tissue adherence. The more reactive materials like 
calcium phosphate, release ions from the surface over a period of time as  well as provide 
protein bond sites. The ions released, aid in promoting hydroxylapatite nucleation 
yielding mineralized bone growing from the implant surface.  
 
One of the first resorbable implant substances used was Plaster of Paris. However, it 
lacks good resorption and mechanical properties and hence the use was limited. Two 
types of orthophosphoric acid salt (a) β-tricalcium phosphate and (b) hydroyxlapatite 
have been used widely as resorbable materials. The ideal Ca/P ratio was observed to be 
10/6 and it was also observed that the substitution of OH with F gave better structural 
properties (Bhaskar et al., 1971). Hyroxylapatites are used for manufacturing various 
forms of implants, solids, porous implants and coating for other implants. The fluoro 
apatites have been observed for better bone formation and increasing in strength of 
osteoporetic strength. The leaching F ions from the ceramic might cause them to become 
incorporated into the surrounding bone thereby strengthening it.  Tri-calcium phosphate 
3CaO.P2O5 is another ceramic with a composition very similar to that of hydroxylapatite 
(Soriano et al, 2000; Sanchez et al., 2001; Baro et al., 2002,). It was also observed that 
tricalcium phosphate degrades faster than calcium phosphate CaO.P2O5   that   degrades   
faster   than   hydroxyphosphate (Panduranga et al, 2002).      Calcium    aluminates 
CaO.Al2O3 were also investigated for orthopaedic applications and it as observed that 
about 50% of this ceramic is resolved in one year in the femur of monkeys and its 
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strength reduced by about 40 % in 3 months.  Metals such as Stainless steel, Cobalt-
chromium, titanium alloys, Platimun, Platimun-iridium alloys have been used in 
orthopaedic load bearing and fixation devices. Other metals include iron, molybdenum, 
chromium, nickel and manganese. Other ceramics such as alumina, zirconia have been 
used in hip, knee and dental implants.  
 
2.1.3 Microorganisms in polymeric implants 
Microorganisms possess variable capacities to adhere to the polymer surface. In this 
respect the Staphylococci are predominant compared with the frequency of the other 
representatives of skin flora. Equally important are the bacteria belonging to 
Pseudomonas group, gram –ve bacilli(actinobacter) enterobacteria (klebsiella, antrobacter 
serratia) and yeast of Candida type. (Dumitriu et al., 1994).  Staphylococcus aureus is the 
important microbil agent in the infections encountered in hemodialysis deviations or in 
vessel prostheses (Liekweg et al., 1977). As for the system of urine collection, infections 
are caused by Pseudomonas aeruginosa (Warren et al., 1984). In the case of chronic 
infections of intrauterine contraceptive devices (sterilete) Actinomycetes has been 
isolated (Schaal et al., 1984). The nature of polymeric materials is important too. In a 
clinical study Staphylococcus epidermis has been isolated in significant frequency in 
venous poly vinyl chloride catheters compared to those of Teflon. This difference is also 
confirmed by in vitro cultures (Seth et al., 1983). In most cases, anti-microbial 
chemotherapy give no results and the danger is eliminated by the removal of the 
prosthesis or the catheter. 
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2.2 Types of Drug Delivery Systems 
A major purpose of conjugating drugs to polymer carrier is to modulate the disposition of 
drugs in the body, a process that allows high therapeutic efficacy with low adverse side 
effects. Drug dosages administered into the body compartments are separated into local 
administration and systemic administration.  Local administration is straightforward in 
that an operation is performed and the drug composition is placed at the required 
position. Systemic administration is classified into several types (Hashida et al., 1994); 
transdermal, transmucosal, peroral, intramuscular, intra-peritoneal, intra-venous, intra-
arterial administration (Agrawal et al, 1994; Sriramkamal et al., 2000).  
 
The movement pathway of drugs in the body alters with administration route. It is 
essential to decrease nonspecific removal of drugs by such organs as kidney and liver. 
Elimination through reticuloendothelial cell system (RES), which is present in liver and 
spleen, is significant for polymer carriers. When the target site is located outside the 
capillaries, the efficacy of extravasation of carrier systems also crucially influences drug 
accumulation at target sites. An obvious effect expected for drug conjugation to 
polymeric carriers is the extended blood half-life due to decreased kidney excretion. This 
effect is not always the case because the biodistribution is influenced by the chemical 
structure of polymers. The threshold molecular weight for glomerular excretion is 
approximately 40,000-70,000 in the case of neutral water-soluble polymers. 
(Kanellakopoulou et al., 2000; Prior et al, 2000; Blanco-Prieto et al., 2002) 
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2.3.1 Composition of Bone 
The bones are classified according to their shape into long, short, flat and irregular bones. 
The long bones are found in the arm, fore arm, thigh and leg. These bones consist of 
elongated shaft of cylindrical compact bone with two extremities having spongy or 
cancellous bone. Short bones have no shaft, but consist of smaller masses of spongy bone 
surrounded by a shell of compact bone. They are roughly box like in shape. Examples of 
such bones are small bones of the wrist(carpus)  and ankle(tarsus). Flat bone consists of 
two layers of cancellous bone. Such bones are found in scapula, innominate bone and 
bones of the skull. Irregular bones cannot be placed in any of the categories, which 
include the vertebrate and some of the bones of the face. Long bones consists of two 
major regions: compact or cortical bone and cancellous or trabecular bone. The location 
of these bone types in a femur is given as fig 2.1.  Cortical or compact bone is a dense 
material with a specific gravity of about 2. The external surface of bone is generally 
smooth and is called the periosteum. The interior surface is called endosteal surface, 
which is roughened. Cancellous bone, which exists in epiphysical and metaphysical 
regions of long bone, is also called spongy or trabecular bone because it is composed of 
short struts of bone material called trabeculae. The connected trabeculae give cancellous 
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     Periosteum 
                         Endosteum 
    Cortical bone                  
                                                                                        Calcellous bone or Alveolar 
 
Fig 2.1 Organization of a typical bone (Sujata, 2000) 
 
From the microscopic viewpoint there are three types of cortial bones; woven, laminar 
and haversian. Woven bone is found typically in both cortical and cancellous regions of 
young, growing animals and in adults after some bone injury. However, during normal 
maturation it is gradually replaced by laminar bone. In laminar and haversian bone, 
minerals and collagen are closely related, whereas woven bone is hyper-mineralized. In a 
wide shaft of a long bone, laminar bone consists of a number of concentrically arranged 
laminae about 10 to 20 mm long. The osteons of haversian bone and laminae are 
basically just different geometric configuration of same material. The interfaces between 
the laminae in both haversian and laminar bone contain an array of cavities called 
lacunae, which contain bone cells and from which extend numerous fine canals called the 
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canaliculi. The thin layer between adjacent osteons is called the cement line (Wei et al, 
1991).  
 
The composition of bone tissue is mainly made of minerals, water and collagenous 
matrix. In order to be more precise about bone composition, one must specify species, 
age, sex, the specific bone and region in question. Wet cortical bone is composed of 
organic matrix [22 % (w/w) of which 90-96 % (w/w) is collagen] and the rest is mineral 
(69 % (w/w)) and water (9 (w/w)). The major mineral consists of submicroscopic crystals 
of calcium apatite Ca10(PO4)6(OH)2 besides phosphate, there are other minor negative 
ions such as citrate, carbonate, fluoride and hydroxyl ions ( Blitz 1969). The apatite 
crystals are formed as slender needles 20-40nm in length and 1.5-3 nm in thickness in the 
collagen fiber matrix. These mineral containing fibrils are arranged into lamellar sheets 
(3-7µm thick), which run helically with respect to the long axis of the cylindrical osteons 
(sometimes called Haversian system). The osteon is made up of 4 to 20 lamellae, which 
are arranged, in concentric rings around the Haversian canal. The metabolic substances 
are transported by the inter communication systems of canaliculi, lacunae and Volkman’s 
canals which are connected with the marrow cavity. It is interesting to note that the 
mineral phase is not a discrete aggregation of the calcium phosphate crystals. Rather it is 
made of a continuous phase as evident from the fact that after complete removal of the 
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2.3.2 Healing of Bone 
Upon bone fracture, many blood vessels are broken. This floods the region of the fracture 
with blood, which clots to form the callus. The pH of the fracture region drops from 
about 7.4 to as low as 5.2. This change of pH aids the decalcification, resorption and 
remodeling of necrotic bone. A certain sequence of cellular events is also observed for 
healing bones ( Hench et al., 1982) 
 
 
   Fibroblasts   Chondroblast      Trobacular      Compact 




  0        2    4 
 
Fig 2.2 Cellular events in bone healing (Hench et al., 1982) 
 
There are basically three types of cellular activity: fibroblastic, chondroblastic and 
osteoblastic activity. Fibroblasts from the periosteum and surrounding tissues proliferate 
vigorously into the region of fracture within 1 or 2 days. During the same period 
capillaries begin proliferating into the wound invading the fibrous callus prior to actual 
new bone formation. Within the first week osteogenic cells begin to migrate from the 
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mucopolysaccharides begins to decrease while collagen production by fibroblasts, 
chondroblasts and osteoblasts becomes significant.  
 
In a little more than a week, collagen fibers bridge the entire gaps of fracture and the pH 
returns to normal. Osteoblasts begin to form new trabecular bone in the marrow. After 2 
weeks a collagen matrix replaces the entire clot and chondroblasts are seen in the region 
between the matrix and the advancing bone growth. After a week or two the uptake of 
calcium and phosphorous into the wound area increases which is attributed to the 
increased rate of bone mineral deposition. By the third and fourth weeks the major 
activity is the replacement of chondroblasts by trabecular bone and after 5-6 weeks the 
major activity is the remodeling of the bone trabeculae with the deposition of compact 
bone. There are two processes by which bone heals. The better known is secondary 
fracture healing, which involves callus formation, resorption of fracture fragments, new 
bone formation and remodeling, where as the primary fracture healing proceeds primarily 
by osteo synthesis. When the two ends are in close contact, very little resorption occurs, 
but some remodeling of osteons in the area takes place. New osteons are formed directly 
at the ends of the fracture and the healing processes are much less complicated than they 
are in secondary fracture healing. 
 
2.3.3 Bone regeneration 
A cancellous auto graft is considered as the most suitable means for the reconstruction of 
bone defects. Allogenic and xenogenic grafts are in comparison disturbed by 
imunological responses. The dispersion of small particles of hydroxylapatite in purified, 
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unimmunogenic and lyophilized collagen sponge yields a composite material named as 
Collapat, which represents a very good bone substitute material. Collapat is regarded as a 
strong bone regeneration-promoting medium in contact with bone. In general, Collapat 
yields good vascularity and favorable bone replacement capability in bone beds and at 
bone surfaces. The decal bone obtained through decalcification of human allogenic bones 
of recently amputated specimens have been used to fill large osteoporous gaps and large 
benign bone cysts in patients. The success rate of graft in the treatment of benign cystic 
bone activity is nearly 80% (Tuli, 1989) 
 
Applications of porous scaffolds made from hydroxylapatite and tri-calcium phosphate 
have now included augmentations of alveolar ridge, periodontal pocket, cystic cavities, 
regions adjacent to implants, spinal fusion, contour and malformation defects, delayed 
and nonunion of long bones and in filling of donor site of autogenous bone transplants. A 
similar material Pyrost is obtained from natural bone by using careful pyrolysis and 
sintering procedure. This material with natural bone structure and mineral content shows 
favorable osteoinductive  activation.  
 
2.4 Analysis of Gentamicin 
Gentamicin was first reported by Weinstein et al. in 1963 and is produced from mainly, 
Micromonosprra purpurea and Micromonospora echjnospora. Amongst the latest 
production processes described in literature the work by Chu et al., 2002 is a typical one. 
Gentamicin is an aminoglcoside antibiotic and is used as an antibacterial agent in humans 
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and animals. There are five known components in Gentamicin. The three major 
components are C1, C1a and C2. The minor components are represented as C2a and C2b.  
 
                                     
Fig 2.3 Chemical structure of Gentamicin. (Flurer, 1994) 
 
Table 2.1 Structure of different components of Gentamicin sulphate. (Flurer et al., 1994) 
 
Gentamicin R1 R2 R3 Mol. Wt. 
C1 CH3 H CH3 477.60 
C1a H H H 449.55 
C2 H CH3 H 463.57 
C2a H H CH3 463.57 
C2b CH3 H H 463.57 
 
Gentamicin can be quantified using polarization fluorescence immunoassay (PFIA) 
(Gurtler et al., 1995), enzyme linked immunosorbent assay (ELISA) (Ara et al., 1995), 
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enzyme immunoassay (EMIT) (Miglioli et al., 1993), fluorescence immunoassay (TDX) 
(Miglioli et al., 1993), microbiologic methods (Reamer et al., 1998) and chromatographic 
methods (Stead et al., 1997). However most of them lack sensitivity and reproducibility 
(microbiologic) and are uneconomical for multiple samples over long periods of time 
(PFIA, ELISA, EMIT, TDX) (Moreno et al., 1998). 
 
For chemicals that obey Beer Lamberts law, spectrophotometric methods of analysis of a 
single component in solution can be done very easily and rapidly. However, detecting 
Gentamicin is a problem because it does not absorb light in UV or visible region of the 
spectrum, as it does not have conjugate carbon atoms. Hence, derivatization using O-
phthalaldehyde (OPA) is necessary. Since OPA by itself does not absorb light in UV-
visual range the detection can be made easily. The isoindoles formed are analyzed. Also, 
the rate of reaction between OPA and Gentamicin play a major role in the analysis as the 
reaction complex, reaction products and the degradation products also absorb light in the 
region.  Either a UV-Visual spectrophotometer (Sampath et al, 1990) can be used or a 
liquid chromatography (Cabenes et al., 1991) can be used after derivatization. Ninhydrin 
as a derivatizing agent was also used (Frutos et al., 2000).  
 
The reactivity of all common derivatization reagents is directed towards the amino 
group(s) in the amino acid structure. Several fluorogenic reagents are available, among 
which O-phthalaldehyde (OPA) / thiol based reagents play the most significant role in 
modern amino acid analysis ( Agarwal, 1989). The most important advantage of OPA is 
that it does not fluoresce intrinsically. The relative drawback is the specificity of OPA 
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only towards primary amines and the instability of resulting fluorophores. Fluorescent 
isoindoles are rapidly formed at room temperature, but subsequently degrade to non-
fluorescent derivatives. Fluorescence quantum yield and stability of “active” derivatives 
are dependent on each particular amine, excess of OPA, but mostly on the nature of the 
nucleophile (thiols) used in the cyclization reaction. Besides thiols, other reducing agents 
such as cyanide or sulphite have also been reported. The following is a comparison of 
fluorescence yield and stability of two model amino acids (glutamate(Glu), γ-
aminobutyrate, also called 4-aminobutyrate, (GABA)) derivatized with different 
OPA/nucleophile reagents. 
 
The best derivatization reagent is the one giving the highest signal and which is easiest to 
prepare, store and handle in the laboratory. Besides the question of a “lab made” vs. 
commercially available OPA solution and its concentration, the most important issue is 
the choice of the nucleophile. 3-mercaptopropionic acid (MPA) seems to be the best 
candidate, since it produces the most stable GABA and other amino acid derivatives. 
Furthermore, amino acids conjugated with OPA/3MPA are more polar because of an 
extra carboxyl group in the thiol moiety. This simplifies optimization of gradient elution 
in HPLC. However, MCE is still the most common additive, probably due to its low odor 
among other liquid mercaptans. Other thiol compounds (N-acetyl-L-cysteine (NAC), N-
acetyl-D-penicillamine (NAP), 1-thio-D-glucose tetra-acetate (TATG)) used for chiral 
separations of enantiomeric amino acids were also tested. NAC gave stable derivatives 
with fluorescent yields comparable to OPA/ MCE (20% lower for Glu). Other thiols as 
well as sulphite and cyanide derivatives gave 10-100 times lower fluorescence than 
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OPA/MCE and therefore are not suitable for physiological amino acid analysis (Kehr, 
1993).  
 
The main apparatus includes a fluorescence detector for improved sensitivity, a reverse 
phase HPLC and pre-column derivatization compared to post-column derivatization (ion-
exchange) for easier maintenance, automation, convenience, reproducibility analysis at 
pico molar levels. OPA-derivatized amino acids (isoindoles) are hydrophobic (non-polar) 
and are thus suitable for reverse phase HPLC separations. Their use allows higher 
sensitivity than ion-exchange chromatography due to better signal/noise ratio and a 
reduced risk of interference from buffers accumulated in the ion-exchange column. 
Reproducibility of quantitative analysis improved dramatically when using a HPLC auto-
sampler for automated derivatization and injections. Cooling and capped vials are also 
necessary.  The detection limit observed in literature is about 0.2 ppm (Toyo’oka,1999) 
The detailed method of analysis using a HPLC and a fluorescence detector will be 













                   CHO    R’-SH    
                                                                     +          R-NH2    
         CHO                   Primary Amine 
        OPA     
 
              SR’                          
                                                                   
                                                           N-R 
   Isoindole 
Fig 2.4 Fluorogenic reaction of primary amine with OPA( Roth, 1971) 
 
In chromatography, the components of a sample are separated by distribution between 
two phases, one a stationary phase a solid or a liquid and the other a moving or mobile 
phase, a liquid gas or supercritical fluid. In early work, problems of high backpressure up 
to 40 MPa resulted from use of long columns (50-100 cm* 1mm ID) and led to the 
technique being called High-pressure liquid chromatography. For shorter columns (25, 10 
or 3 cm) the preferred name is high performance liquid chromatography.  
 
Mobile Phase: One system of classification recognizes the importance of the mobile 
phase and divides chromatography into three broad areas of liquid chromatography, gas 
chromatography and supercritical fluid chromatography depending on whether the 
mobile phase is a liquid, gas or supercritical fluid. Further classification is possible by 
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specifying both the mobile and stationary phases leading to gas-solid and gas-liquid 
chromatography in which a gas is mobile phase and the stationary phase is either solid or 
liquid. The technique of supercritical fluid chromatography is called by the same name 
irrespective of the stationary phase.  
 
Reverse phase and normal phase chromatography: In liquid chromatography, systems 
involving a polar stationary phase and a non-polar mobile phase are termed normal phase 
systems. With the combination of phases, solute retention generally increases with solute 
polarity. Conversely if the stationary phase is less polar then the mobile phase the system 
is described as reversed phase and polar molecules have a lower affinity for the stationary 
phase and elute faster. Reversed phase chromatography is more common in liquid 
chromatography than normal phase. With the normal phase systems increasing the mobile 
phase polarity makes it more like the stationary phase so that the mobile phases compete 
more effectively with the stationary phase for solute molecules. The solute molecules 
therefore spend less time in the   stationary phase and elute faster. Using a similar 
argument it can be said that slower elution is possible when mobile phase polarity is 
increased in reversed phase chromatography (Robbards et al, 1994). 
 
There are two types of techniques in which the stationary phase is supported on a planar 
surface: paper chromatography and thin layer chromatography, which are together called 
planar chromatography and in the case where a column is present, it is called column 
chromatography. The nature of interaction between the sample and mobile phase also 
forms a basis for classification. The forces involved in these interactions are usually weak 
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intermolecular forces such as van der Waals forces or hydrogen bonds. In certain cases 
ionic interactions and in rare cases charge transfer forces are observed. The mechanisms 
that are involved are: adsorption, partition, bonded phase, ion exchange, ion interaction, 
size exclusion, affinity micellar, complexation, ion exclusion and counter current 
chromatography.  
                         
CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Materials 
Poly (DL-lactic-co-glycolic acid 50:50) (mol. wt. 40,000 – 75,000), poly (DL-lactic-co-
glycolic acid 65:35) (mol. wt. 40,000 – 75,000), poly (DL-lactic-co-glycolic acid 85:15) 
Gentamicin Sulfate USP, O-phthalaldehyde, O-phthaldialdehyde, Boric Acid, 2-
mercaptoethanol, methyl cellulose, poly ethylene glycol mol. wt 1450, poly ethylene 
glycol mol. wt. 3350, polyethylene glycol mol. wt. 8000, poly vinyl alcohol mol. wt. 
30,000-70,000, phosphate buffer saline (PBS) (NaCl-0.138M, KCl-0.0027M, 0.01M 
phosphate buffer saline) used for in vitro release study were all purchased from Sigma 
Aldrich (St. Louis, USA). Ethyl acetate, dichloro methane and methanol are from Tedia 
(Fairfield, OH, USA). Hydroxylapatite is from Raedel-de-Haen, Seelze, Germany. Beta-
tricalcium phosphate is from Fluka (Steinheim, packed in Switzerland). Sodium 
hydroxide and acetic acid are from Merck (Darmstadt, Germany). 1-heptane sulphonic 
acid sodium salt is from Acros (New Jersey, USA) and Aldrich (Steinheim, Germany).  
 
3.2 Preparation of micro particles and discs 
One gram of the required polymer was dissolved in 50 ml of ethyl acetate (if two types of 
polymers are used, then the total weight of polymer is one gram). If polyethylene glycol 
(PEG) or methyl cellulose (MC) was used (along with PLGA), then dichloromethane was 
used as solvent, as PEG is not soluble in ethyl acetate. MC can only be suspended in the 
dichloromethane solution (the solution turns turbid) and it cannot be suspended in ethyl 
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acetate. In the case of Gentamicin being used as a solution, it was dissolved in 1ml of 
water. If solid was used, then it was directly poured into the solution. In either case, the 
mixture was ultra-sonicated at 15 W for three times, for 20 seconds each time (Misonix 
Inc, XL 2000, USA).  
 
The mixture was then spray dried in Buchi 191 Mini Spray Drier (Flawil, Siwtzerland) at 
70°C, airflow rate of 700Nl/h; pump feed rate of 30 % and an aspirator ratio of 100 %. 
The outlet temperature is observed to be between 45 and 50°C. The microparticles 
obtained were freeze dried (Christ Alpha 1-2 Model 100200, Germany) over night for the 
elimination of the solvents and water that may be present. The particles were then stored 
in a dessicator for later use.  
 
For the preparation of discs from all types of materials except hydroxylapatite and β-
tricalcium phosphate, the required amount of microparticles were weighed and the discs 
were prepared in a 5mm evacuable die at 2 ton pressure for 5 minutes using a Graseby 
Specac (Orpington, Kent, United Kingdon)  set up. The discs thus prepared were again 
stored in dessicator. For the preparation of discs with the calcium phosphates, the 
required amount of each of microparticles and the calcium phosphate were blended using 
a mortar and pestle and then compressed under the same conditions as described before.  
 
3.3 Encapsulation efficiency and Analysis of Gentamicin 
Five milligrams of the microparticles were dissolved in 1 ml dichloromethane and 5 ml of 
water was added to it after the microparticles are well dissolved. Gentamicin being 
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hydrophilic will be separated into the water phase on vortexing. The water phase was 
analyzed for Gentamicin content using a high performance liquid chromatography 
(HPLC). The procedure for the analysis of Gentamicin is described below.  
 
O-phthalaldehyde (OPA) reagent was prepared by weighing 50 mg of O-phthalaldehyde 
in an amber vial and 1ml of methanol was added to it. 40 µl of 2-mercaptoethanol was 
added to this. The mixture of methanol and 2-mercaptoethanol is called OPA solver and 
has a flash point of 10°C. Borate buffer was prepared as follows: 0.4 M boric acid was 
prepared and the pH was adjusted to 10.5 using highly concentrated NaOH. The OPA 
solver (1 ml) along with OPA was mixed with 9 ml of the borate buffer and left overnight 
at 4°C. The reagent was always prepared freshly and was used within 3 days from the 
date of preparation. The solution was discarded if solid particles are formed during the 
storage process. 
  
OPA reagent (0.1 ml) was added to 0.5 ml of the Gentamicin solution and a florescence 
detector was used for the detection. Shimadzu 10ADvp system with a workstation was 
used. Excitation wavelength and emission wavelength are 332nm and 445 nm 
respectively. A Lichrosorb RP 18 column with particle size 5 µm and 250 mm * 4 mm 
size from Merck  (Dramstadt, Germany) was used for separation. The mobile phase was 
prepared by 20 ml acetic acid, 180 ml water, 800 ml methanol and 4.5 grams of 1-
heptane sulphonic acid sodium salt per liter of the mobile phase. All reagents used were 
of HPLC grade and they along with samples were filtered before running the HPLC. 
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3.4 Morphology, particle size distribution and DSC 
Scanning electron microscope is used to study the morphology of the micro particles and 
discs. A Joel JFC-1100E, Japan instrument was used. The particle size distribution was 
studied by laser light scattering technique using a Brookhaven 90 Plus particle size 
analyzer, Holtsville, New York, USA. The Differential Scanning Calorimeter (DSC) 
from TA Instruments (New Castle, Delaware, USA) was used to study the   extent of 
degradation of the polymer.  
 
3.5 In vitro release 
In vitro release from the microspheres was done for 10 mg of the particles in centrifuge 
tubes with 20 ml of the PBS buffer at pH 7.4 and 37°C in a water shaker bath at 110 
rev/min. 50 mg of Tween 80 was added to one liter of PBS to suspend the microspheres.  
At specified intervals of time the supernatant solution was taken out after centrifugation 
at 10,000 rpm for 10 minutes and was replaced with fresh PBS solution. In the case of in 
vitro release from discs, no Tween 80 is added to PBS and samples are taken directly as 
the disc remains at the bottom of the tube. 
 
3.6 In vivo study on rabbit model 
White New Zealand rabbits weighing between 2.2 and 2.8 kg were used in the study. 
Anesthesia was given at 35 mg/kg of Ketamine and 5 mg/kg of Xylazine. During the 
surgical procedure, a hole of about 5 mm * 10 mm was drilled in the femur bone’s 
intercondylar region. The medullar cavity was reached while avoiding damage to the 
ligament insertions and the polymeric discs containing Gentamicin were implanted in the 
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bone. A suture closes the surgical wound and the animals are disinfected and are left for 
free movement in the cages after recovery from anesthesia. The blood samples were 
collected from the bone and the ear at specified intervals of time in order to measure the 
local area concentration and systemic concentration of Gentamicin respectively. For 
another batch of rabbits, a first operation was performed as above and PMMA beads were 
implanted instead of the polymeric discs containing the Gentamicin. The size of the 
PMMA beads was about 5 cm and three to four beads were used in each rabbit. After two 
weeks of implantation of the PMMA beads, they were removed by a second surgical 
procedure and the polymeric discs with Gentamicin were implanted. The similar steps 
were followed for blood sampling. In both the methods one rabbit from each of the batch 
were sacrificed and the extent of degradation of the polymer was studied.  
 
The samples were stored at 4°C and the blood serum was extracted for analysis at a later 
stage. The Gentamicin content in the serum was determined by using a Microgenics 
Gentamicin II Therapeutic Drug Measuring Kit in a Hitachi 717 analyzer at 330 nm.  
    
    
   
CHAPTER IV 
RESULTS AND DISCUSSION 
 
The successful treatment of Osteomyelitis involves local administration of a composition, 
which gives a sustained release of Gentamicin for a period of about 6-8 weeks. 
Throughout the study, our effort has been directed towards preparing a composition that 
is viable for use. Since an operation is performed and the composition is placed at the 
infected area, size of the particle need not be small and it is not necessary that the 
composition be delivered in the form of microspheres. The only obvious restriction is that 
the size of the particle developed should be small enough to fit into the bone for study in 
animal models. The various stages through which the project has gone through are given 
below. 
A.) In vitro release from microspheres 
B.) In vitro release from discs made by compressing the microspheres 
C.) In vitro release from discs that are modified with the addition of PEG and methyl 
cellulose 
D.) In vitro release from discs made from a blend of microspheres and calcium 
phosphates 
E.) In vitro release from discs that are made when Gentamicin is used as solid 
F.) In vivo study on rabbit model 
A large part of the study (part A to part D) has been directed towards the modification of 
the porosity of the disc in order to modify the release profile. They will be presented in 
one broad section as section 4.1. The samples from part E have given a profile that is 
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more acceptable and hence this is discussed as a separate section as 4.2. The samples 
from part E are used for in vivo studies, and in section 4.3 the results and discussion of 
this is given. 
 
4.1 Modification of porosity of discs  
 
Microspheres can be prepared by several methods and Gentamicin being a very 
hydrophilic drug tends to separate out into the water phase mostly if water is one of the 
major components in the fabrication process. Hence solvent evaporation technique was 
not used as it generally contains a water phase and the encapsulation efficiency is largely 
reduced and hence a large amount of the polymer would be required in order to deliver 
the required amount of the drug. All along this study spray drying was employed as the 
main fabrication process as only about 1ml of water was used to prepare Gentamicin 
solution. This was added to 50 ml of solvent and is relatively small and can be distributed 
in ethyl acetate by ultra-sonication.  The encapsulation efficiency was also large and was 
around 50 % for all the spray drying that was performed.  
 
Microspheres were fabricated using PLGA 50:50, PLGA 65:35 and PLGA 85:15 and it 
was observed that the microspheres from all the three types of polymers released the drug 
in less than one day. A theoretical drug loading of 4 % was used as it was observed by  
Wang and coworkers (Wang et al, 2001) that the increase in drug loading would reduce 
the encapsulation efficiency thereby keeping the drug content per unit weight of polymer 
at an optimum level. The particle size was between 1-2 um which was generally what 
was expected from a spray drying process. The SEM of the microspheres showed that the 
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shape deviated from being spherical as the crystallinity of the polymer decreased and also 
there was large-scale agglomeration. The crystallinity of the PLGA is directly related to 
the glycolic content with PLGA 85:15 being largely crystalline and PLGA 50:50 being 
relatively less crystalline. It also appears that the size of the particles changes the type of 
the polymer used and it may be related to the amount of agglomeration where more than 
one microsphere tend to agglomerate to for a larger microparticle. 
 
Table 4.1 The encapsulation efficiency and particle size of the microspheres prepared  
using three types of PLGA. EE: encapsulation efficiency.  
 
Sample EE % Size (um) 
PLGA 50:50 54.4+4.4 1.8 + 0.1 
PLGA 65:35 60.5+4.5 1.5 + 0.1 





























Fig.4.1 The SEM of microspheres made using three types of PLGA. A: PLGA 50:50. B: 
PLGA 65:35. C: PLGA 85:15 
 





























Fig. 4.2 The release of Gentamicin from the microspheres made using three types of 
PLGA . 
 
Implantable discs made by compressing the microspheres were prepared for the next 
part of the study. The study was directed towards the preparation of discs as it can be 
observed from the Fig. 4.2 that the microspheres have released all of the Gentamicin in 
less than a day and that the hydrophobic-hydrophilic nature of polymers used did not 
have much effect on the release profile. It appears that almost all of the Gentamicin 
remains close to the surface of the microspheres and hence it is released in very less time. 
It can also be inferred that the size of the particles may play a larger role in the release of 
Gentamicin.  Varying the fabrication conditions like temperature, flow rate of air and 
aspirator ratio will only change the size of the microspheres by a fraction of a micrometer 
or a few micrometer and hence the release can be expected to be only a day or more.  
 




The microspheres made of different types of PLGA were compressed into a 5 mm discs 
and the in vitro release was studied. It was observed that the discs give a biphasic 
behavior. There was an initial release observed which can be attributed to the release of 
Gentamicin from the microspheres that are present close to the surface when compressed. 
Then there was a lag phase observed as a result of no Gentamicin being released from the 
disc. It appears that the disc remains largely impermeable to water and thus there is no 
release of Gentamicin. The lag phase was followed by a second release, which can be 
attributed to a stage where the bulk degradation of the polymer reaches a critical level 
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Fig.4.3 The release of Gentamicin from discs made by compressing PLGA microspheres 
(microspheres of PLGA 65:35 and PLGA 50:50 are compressed into discs). 
 
PEG modified discs are prepared with an intension of modifying the porosity of the 
discs. It appears that by modifying the porosity of the discs made of PLGA microspheres 
we will be able to modify the lag phase and the amount of initial release of Gentamicin. 
Hence polyethylene glycol (PEG), which is a water-soluble polymer, is added to the 
PLGA solution before spray drying in order to achieve uniformity. It is anticipated that 
PEG will diffuse out of the discs leaving some pores and Gentamicin will follow the 
through the pores giving a larger initial release which may eliminate the lag phase. 
 
In the study the effect of PEG content on the release profile was investigated. The effect 
of molecular weight of the PEG used was also investigated. It can be observed from fig. 
4.3 that PLGA 50:50 releases Gentamicin faster (as compared to PLGA 65:35 discs) and 
degrades faster and hence for all the study of the modification of the discs, PLGA 50:50 











                                                                                      Chapter IV: Results and Discussion 
________________________________________________________________________ 
 43
Table 4.2 Different percentage of PEG and different molecular weight of PEG was used, 
while the microspheres were prepared. Seven samples A to G are prepared. A: 2% PEG 
(mol. Wt. 8000). B: 5% PEG (mol.wt 8000). C: 10% PEG (mol. Wt 8000). D: 15% PEG 
(mol. Wt 8000). E: 20% PEG (mol. Wt 8000). F: 10 % PEG (mol. Wt 3350). G: 10% 
PEG (mol. Wt 1450). For all samples PLGA 50:50 was used as the main polymer along 
with PEG. 
 









The SEM pictures have shown increased agglomeration when PEG is added to PLGA 
and hence it was not possible to calculate the size of the particles formed. Also, the 
particles are not being used directly for in vitro release and it has already been observed 
previously that small change in the size of the particles does not change the release 
profile mostly. It can be said that the particles lose their identity when they are 
compressed to form a disc. Hence the process of spray drying the Gentamicin solution 
along with the polymer solution is mainly in order to achieve a much uniform product in 
terms of microparticles, which ensure a uniform distribution of Gentamicin and polymer 
in the disc. 
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Fig. 4.4 SEM of different microparticles on the addition of PEG to PLGA. A: 20 % PEG. 
B: 15 % PEG. C: 10% PEG. D: PEG mol.wt 3,350. E: PEG mol.wt 1450. F: 5% PEG. G: 
2% PEG. The mol.wt of A, B, C, F and G is 8,000. D and E has 10% PEG. For all 
samples PLGA 50:50 was used as the main polymer along with PEG. 
 
 
The results from Fig. 4.6 shows that by adding PEG to PLGA and compressing the 
microparticles into discs will only change the release by changing the initial release and 
changing the position in time where the second release starts. However the shape of the 
release curve remains largely of the same type, which again is a biphasic behavior. It was 
observed that adding about 2% ~5% PEG does not change the profile much as compared 
to the pure PLGA discs and there is a small change in initial release. However, when 
about 10 % of PEG is added, the initial release of Gentamicin largely increases. When the 
content is increased further, the initial release increases greatly and almost the entire drug 
comes out in the initial release itself. It was also observed that the dimensions of the disc 
do not play a major role as can be seen when the mass of the disc is varied from 25 mg to 
35 mg (fig 4.6). 
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It can be observed that the initial release increases as the content of PEG increases. It can 
also be seen from the SEM pictures that when PEG is added to the PLGA while spray 
drying and the microparticles are compressed into discs there are some pores observed in 
the discs. Hence, from Fig 4.5 and 4.6 it can be said that the addition of PEG increases 
the initial release. It was also observed that the smaller the molecular weight of the PEG 
added the higher is the initial release. However it appears that there is not much effect in 
terms of where the second release starts. It is certain that the second release starts earlier 
that that of the pure PLGA microparticle compressed discs. During the process of in vitro 
study, it was observed that the discs start to change their color and become transparent. 
This can be attributed to the point where PEG comes out of the disc rapidly or when the 
time where PLGA starts to degrade largely. It is more likely that the PEG starts to come 
out of the disc before PLGA starts to actually degrade and this can be seen from the SEM 



































Fig 4. 5 SEM picture showing extent of degradation in PEG-PLGA discs. A: 2% PEG 
mol.wt 8,000. B: 5% PEG mol.wt 8,000. C: 10% PEG mol.wt. 8,000. D: 10% PEG 
mol.wt 3,350. E:10% PEG mol.wt 1,450. A, B, C, D, E are after 20-day release. F: 10% 
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PEG mol.wt 8,000 before release. For all samples PLGA 50:50 was used as the main 






























Fig. 4.6 (a) In vitro release from PEG-PLGA discs. (Notation is same as table 4. 2). C: 
10% PEG (mol. Wt 8000). F: 10 % PEG (mol. Wt 3350). G: 10% PEG (mol. Wt 1450). 
For all samples PLGA 50:50 was used as the main polymer along with PEG. Mass of all 
discs is 25 mg except for C-35 it is 35 mg.  
































Fig. 4.6 (b) In vitro release from PEG-PLGA discs. (Notation is same as table 4.2). A: 
2% PEG (mol. Wt. 8000). B: 5% PEG (mol. wt 8000). D: 15% PEG (mol. Wt 8000). E: 
20% PEG (mol. Wt 8000). For all samples PLGA 50:50 was used as the main polymer 
along with PEG. Mass of all discs is 25 mg. 
 
 
Methyl cellulose formed another polymer that was used along with PLGA to prepare 
microspheres with an intention of investigating the effect of possible change of porosity 
and polymer type on the release characteristics. Methyl cellulose is not soluble in ethyl 
acetate and it does not form a suspension either. Hence dichloromethane was used in the 
fabrication of methyl cellulose-PLGA microparticles. When dichloromethane is used, 
methyl cellulose forms a turbid solution. It may be that only the methyl side group tends 
to dissolve in solution whereas the cellulose backbone remains suspended hence giving a 
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turbid look. As it does not form a uniform solution, the uniformity of the microparticles 
formed by using methyl cellulose may not be high.  
 
Table 4.3 Encapsulation efficiency for methyl cellulose-PLGA microparticles. MC is 
methyl cellulose and the number represents the percentage of MC in total weight of 
polymers. For all samples PLGA 50:50 was used as the main polymer along with PEG. 
 
Sample EE % 
Methyl Cellulose 2% 54.8+3.2 
Methyl Cellulose 5% 50.3+3.5 










Fig.4. 7  SEM picture of methyl cellulose-PLGA microparticles. A: 2% MC in PLGA 
50:50. B; 5 % MC in PLGA 50:50 






























Fig. 4. 8 In vitro release from methyl cellulose-PLGA discs. For all samples PLGA 50:50 
was used as the main polymer along with PEG. 
 
It can be seen in the release profiles from the methyl cellulose-PLGA discs where the 
release tends to be very much fluctuating which can be attributed to the fact that there is 
large uniformity. The Fig 4.8 shows that the release becomes much faster as the amount 
of methyl cellulose which is similar to that when PEG is added. The profile is a better 
one, however, since there is the possibility of large-scale non-uniformity, reproducibility 
is a cause for concern.  
 
Calcium phosphate blended discs are prepared and tested whether they are successful in 
the modification of the porosity so as to achieve a release time of about 6 weeks and an 
acceptable release profile. Hydroxylapatite and β-tricalcium phosphate are the bone 
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forming biomaterials and are biocompatible. In order to prepare the discs, the 
microspheres were prepared from pure PLGA and are then blended with the calcium 
phosphate in the required ratio and the in vitro release is studied. Hydroxylapatite is a 
much better biocompatible material compared to β-tricalcium phosphate but it is 
relatively difficult to compress it into a disc as the surfaces and edges tend to break. 






























Fig. 4.9 (a) In vitro release discs made by blending β-tricalcium phosphate (at 60%) and 
microspheres. TCP: β-tricalcium phosphate.  






























Fig. 4.9 (b) In vitro release discs made by blending hydroxylapatite(at 60%) and 





















Fig. 4.9 (c) In vitro release from β-tricalcium phosphate and microspheres blended discs 
at 40% and 30% calcium phosphate with PLGA 50:50 microspheres. T: β-tricalcium 
phosphate. 
 
It was observed from the in vitro release data that when small quantity of the order of 
90% of the total weight is the disc is the calcium then all of the Gentamicin comes out 
very fast and it appears that the porosity becomes very large and the discs gives a similar 
release to that of the microspheres. The amount of the calcium phosphate was later 
reduced to about 60 % of the total weight of the disc and it was observed that the release 
profile could be modified to an acceptable one. However, the time of release remains to 
be about two weeks, which is still very short of the required release time of 6-8 weeks. 
Here it can be observed that the hydroxylapatite blended discs give a haphazard release 
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observed after compressing the discs. It is now apparent that the reduction in the calcium 
phosphate content can actually reduce the porosity of the disc and hence release the 
Gentamicin slowly. It was also observed that there is not much effect of the type of the 
PLGA that was used to prepare the microspheres.  
 
As hydroxylapatite is difficult to compress into discs, only β-tricalcium phosphate was 
used for the remaining study. As is can be seen that the calcium phosphate content 
determines the release time, the content of the ceramic was further reduced in order to 
reduce the porosity of the disc. By doing so it was observed that the release shifts to a 
biphasic behavior where there is an initial release followed by a lag phase, which is 
followed by a second release, and this is similar to the PEG-PLGA discs. Hence it may be 
said that the content of the additive can only be above a critical value below which the 
release is biphasic. It was observed during the process of in vitro studies that the lesser 
the content of the calcium phosphate that is added to the disc, the more it retains its shape 
to that of the original. The more it is added, the faster the disc expands in size most 
probably due to the increased porosity and the easy of water uptake. Also, the blending 
process of the microspheres and the calcium phosphate has a disadvantage in that it is a 




4.2 The usage of Gentamicin as a solid 
The later part of the study is focused on the development of a drug delivery system that 
works for a longer period even for the hydrophilic drug considered here in this study. 
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Hence, we have tried to fabricate the microparticles keeping the Gentamicin as a solid 
and hence allowing for much greater accesses to Gentamicin (for the water) when a disc 
is compressed. The intention was to develop a composition where the drug is readily 
available to the water phase for a longer period of time, in other words to extend the 
initial release to a greater extent thereby allowing for pores to form where the drug was 
previously present. It was observed that the second release for pure discs starts late and 
this should start early for the composition to be successful.  
 
Table 4.4. Encapsulation efficiency for the microparticle and Gentamicin mixture. GS: 
Gentamicin sulphate. Number represents drug loading. The ratio is that of PLGA85:15 
and PLGA 50:50. 
 
Sample EE % 
GS10 (PLGA 50:50 only) 50.1+3.8 
GS15 (PLGA 50:50 only) 49.0+3.3 
GS20 (PLGA 50:50 only) 34.0+4.3 

























                                                                                      
 
 
Fig 4.10 SEM pictures of microparticles of high drug loading of Gentamicin. A: 10%. B: 
15%. C: 20%. D:25% drug loading in PLGA 50:50. 
 
It can be observed from the in vitro release curves that when a solid is used and 
microparticles are compressed into discs, about 60 % of the Gentamicin comes out in 
about 5 days and the rest comes out in another 25 days. It is felt that when solid 
Gentamicin is used, the microparticle mixture will be similar to small particles of 
Gentamicin being blended uniformly with the microspheres of the polymer and at the 
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same time the Gentamicin will be coated with a layer of the polymer. When about 60 % 
of the drug is released there will be enough pores for water to penetrate inside the disc 
and since Gentamicin will only be as solid the possibility that the water phase comes in 
contact with the drug is higher than when microspheres are compressed because the 
microspheres will act as a secondary protection to the Gentamicin that is distributed at the 































Fig.4. 11 (a) In vitro release of Gentamicin (GS) from high drug loaded discs. The effect 
of different theoretical drug loading (10%, 15%, 20% and 25%) is studied. 
 






























Fig.4. 11 (b) In vitro release of Gentamicin from 10% drug loading. The ratio of PLGA 
85:15 and PLGA 50:50 are used to study the affect of hydrophobic-hydrophilic nature of 
polymer. 
 
When pure PLGA 50:50 was used with higher drug loading it was observed that as the 
drug loading increases the encapsulation efficiency decreases. On observation, it can be 
seen that the drug content per unit weight of the polymer remains at about the same value 
and hence it is felt that that 10 % drug loading is an optimum value.  As it was observed 
that the initial release was a bit high PLGA 85:15 was added to the PLGA 50:50 in order 
to introduce a more hydrophobic nature to the disc which may help in bringing down the 
initial release and hence making more of the drug available for later part of the release. 
However, it appears that there is not much effect on the type of the polymer used and the 
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extent of hydrophobic and hydrophilic nature of the polymer. It may be possible that 
when there are large pores present in the disc, the possibility of water to penetrating into 
the disc increases and if we assume a perfect cylinder, we may see that as the diameter 
increases, the influence of the hydrophobic-hydrophilic nature of the surface decreases as 
the amount of bulk fluid present would increase giving a system where the release would 
probably depends on the size of the Gentamicin particles.  
 
4.3 Rabbit models for In vivo study 
As it can be observed that the samples from the previous section give decent in vitro 
release profile, they were chosen for performing the in vivo studies that were performed 
on rabbit models. Male New Zealand white rabbits were chosen for the study and all the 
animals weighed between 2.2 kg and 2.8 kg. An operation was performed as discussed in 
the section 3.6 and three discs of the polymer loaded with Gentamicin were placed in the 
cavity. Samples were prepared from 10 % drug loading microparticles that had an 
encapsulation efficiency of about 50 % and each disc was 140 mg giving the drug loaded 
in each of the disc to be 7 mg approximately.  
 
It was intended that the experiment be planned in such a way that we can assure sufficient 
local area concentration at the bone and low systemic concentration that can be tested by 
taking blood samples from the hole made in the bone and from the ear. Samples from the 
ear would sufficiently give the data pertaining to the systemic concentration and hence 
we can say that the Gentamicin levels in the liver and kidney will also be similar. In total, 
four batches of rabbits were studied in vivo. Two batches were studied according the first 
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procedure and two batches were studied according to the second procedure, which 
included an additional operation to implant the PMMA beads. Each batch had three 
rabbits for taking data in triplicate. 
 
For the first protocol, samples were implanted during the first operation and samples 
were collected from the local area and ear at 1 day, 3 day and 7 days. During the process 
of blood sampling it was observed that the amount of blood collected from the local area 
was not very much and was generally between 0.1 ml to 0.5 ml on each collection and in 
certain cases no blood was collected. This may be due to the fact that there might have 
been a blood clot developed due to the hole that was made in the bone and the blood loss 
caused due to the procedure. Hence, blood samples beyond the one week period were not 
collected from the local area. However, blood was collected from the ear for a period of 6 
weeks from the day of operation in order to monitor the systemic concentration. The 
results for the first week are presented in table 4.5. It is seen from the results of the two 
batch of rabbits that though we can say that the local area concentration from the bone 
was high compared to the systemic concentration by a factor of between 1 and 2, 
however, we cannot confirm which of the disc is more suited for the in vivo release as the 
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Table 4.5 Shows concentration from two batches of samples in µg/ml. For rabbits 1 to 3 
and 4 to 5, the discs made using PLGA 85:15 and PLGA 65:35 in the ratio 7:3 and 5:5 
are implanted. E: ear. L: leg. 
 
Day 1E 1L 2E 2L 3E 3L 
1 0.17 2.7 0.02 2.29 - 13.53 
3 0.03 15.51 0.18 10.32 0.07 3.24 
7 0.07 24.45 0.58 6.84 1.43 4.97 
 
Day 4E 4L 5E 5L 6E 6L 
1 0.16 5.86 0.33 6.01 0.14 5.44 
3 - 5.86 0.48 3.03 0.12 16.16 
7 0.14 - 0.25 18.08 0.13 5.77 
 
As the blood sampling procedure was difficult and no blood was collected beyond the 
first week, the protocol was changed with a view of getting rid of the blood clot and 
hence increasing the chances of sampling blood from the bone region.  
 
Two rabbits one each form the batches of the first protocol were sacrificed at 6 weeks 
time to study the extent of degradation. The other animals were not sacrificed and are left 
for reuse in accordance with the animal ethics guidelines. The X-ray was taken for the 
bone to check for the extent of bone growth for each of the rabbits and it was observed 
that there was certain amount of bone growth (Fig. 4.12). The samples of polymers 
collected from the bone region have shown sufficient degradation when analyzed by a 
DSC (Fig. 4.13). The figure shows the boiling point of residual solvent and the melting 
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point of the polymer for 1:1 mixture of PLGA 85:15 and PLGA 50: 50 (sample A). The 
sample with less amount of PLGA 85:15 (sample B) degrades completely as  compared 
with sample C, which is a 7:3 mixture of PLGA 85:15 and PLGA 50:50. This can be 
observed from the trough for sample C, which is the result of the polymer loosing its 














Fig. 4.12 An X-ray showing the extent of regeneration of bone after a 6-week period. 
 
















Fig. 4.13 DSC data showing the amount of degradation of each sample in vivo. A: pure 
1:1 mixture of PLGA 85:15 and PLGA 50:50. B: PLGA 85:15 and PLGA 50:50 at 1:1 
ratio (sample 5:5) after 6-weeks of in vivo study showing that there is large scale 
degradation and possible migration of polymer. C: PLGA 85:15 and PLGA 50:50 in the 
ratio 7:3 after 6-weeks of in vivo shows that some of the polymer is not degraded. Tb is 
boiling point of the residual solvent and Tm is melting point. Negative y-axis represents 
the endo- thermic process. 
 
In the second protocol, as described before PMMA beads are implanted in the first 
operation and the rabbit are left for free movement. After a period of two weeks a second 
operation was performed to remove the PMMA beads and the discs are implanted. It was 
observed that as the hole was drilled two weeks earlier, a certain amount of bone growth 
is observed and it is difficult to remove the beads. It is felt that a single long cylindrical 
type of PMMA be implanted inside the bone allowing for easy removal during the second 
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tissue formation around the bone. Also, if the time is longer, the chances of more of 
unwanted growth might occur along with more regeneration of the bone which may 
require the use of a drill giving a scope for a major bleeding thereby increasing the 















Fig. 4. 14 A step-wise pictures to show the procedure of operation for the second time to 
remove the PMMA beads and implant the discs. A: Rabbit after two weeks of frist 
operation. B: Removal of PMMA beads implanted in first operation. C: PMMA beads 
that are removed from the rabbit femur after two weeks of implantation. D: The PLGA 
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Table 4.6 Shows concentration from two batches of samples in µg/ml. For rabbits 7 to 9 
the discs made using PLGA 85:15 and PLGA 65:35 in the ratio 9:1 and for 10 to 12 pure 
PLGA 50:50 was used. L: leg. 
 
Day 7L 8L 9L 10L 11L 12L 
1 0.44 0.59 -- -- 0.6 0.55 
3 0.54 1.31 -- 0.07 -- -- 
7 0.29 -- 0.23 0.32 0.09 -- 
14 -- 0.23 -- 2.82 -- -- 
21 0.43 -- -- -- -- -- 
 
It was observed that the sampling procedure from the bone area was relatively easier and 
about 0.5 ml was collected each time. However, it remains that the probability of 
collecting the samples mainly depends on the animal with most of the animals giving 
some blood but there were some, where no blood was collected. The results are presented 
in table 4.6 
 
It can be observed that the concentration is low. This can be attributed to the fact that the 
samples collected were more of body fluid and less of blood. It appears that the diffusion 
of the drug into the surrounding tissue that has grown after the first operation is very 
limited. Also, the concentration in the ear is zero. However, there is some concentration 
in the animals after 14 days and in order to verify that the composition is actually 
successful the study of infected rabbits should be performed. Some samples were not 
collected and hence, a blank is shown. 
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5.1 Conclusions 
It was observed that the microspheres released most of the Gentamicin in less than a day 
and the size of the drug delivery system largely influences the release time. Hence 
microspheres were compressed into discs and studied in vitro. It was observed that the 
discs give a biphasic behavior. Hence most of our effort was directed towards the 
fabrication of a delivery system that is a disc and many modifications were done to the 
discs with a view of changing the porosity and hence changing the release profile. 
Different types of biomaterials were chosen for the modification of the porosity of the 
discs in anticipation of achieving a release curve that can be used for in vivo studies at a 
later stage. From different molecular weights of PEG to the two types of calcium 
phosphates and methyl cellulose, all the additives did not give a satisfactory change in the 
release curve.  
 
Later during the study, the fabrication was directed towards making a delivery system, 
which was similar to a large microsphere. Hence, solid Gentamicin was suspended in the 
polymer solution and was spray dried. By doing this, a nearly uniform mixture of 
Gentamicin and the polymer particles can be achieved.  The product was then 
compressed into a disc and the in vitro release is studied. When Gentamicin solid was 
ultra-sonicated in a polymer solution the solid split into smaller pieces and become more 
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uniform. Higher drug loading of 10 % and above were used and it was observed that this 
drug loading would be optimum. When the discs were tested in vitro, the initial release 
tends to be large and lasts for up to 5 days and this can be attributed to the fact that most 
of the solid tends to come out of the disc and leave considerable pores in the disc.  Then 
the remaining Gentamicin came out slowly depending of the rate at which water 
penetrated in to the disc. The results were considerably satisfactory with a total release of 
about 30 days and hence these samples were tested in vivo. In order to see if the type of 
polymer influenced the release profile, different types of PLGA were used and it was 
observed that the type of the polymer did not influence the release profile very much. 
 
The samples made of different types of polymers were then tested on healthy rabbit 
femur as part of the in vivo study. It was observed that a blood clot formed when a hole 
was drilled into the femur and the discs were placed. Hence, in order to get rid of the clot, 
an operation was performed to put PMMA beads and they were removed after two weeks 
by the second operation and the discs were implanted. These procedures gave satisfactory 
results in that the local concentration at the bone was high and the systemic 
concentration, which was measured from blood samples from the ear, was less. 
 
  
5.2 Recommendations for Future work 
Since the in vivo results from healthy rabbits was successful, the next step should be the 
work on rabbits infected with the bacteria, as this would further establish the efficacy of 
the composition.  
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The work done here was related to bone infection and in the process utmost care was 
taken to use materials that can help for the formation of the bone or are biodegradable. 
As, during the development of Osteomyelitis and its cure, the tissue and the bone near the 
infected area tend to die and we may further try to work with rhBMP-2 (recombinant 
human bone morphogenetic protein-2), VEGF (vascular endothelial growth factor) and to 
further the area of research into bone, bone tissue and articular cartilage regeneration. 
 
Some other biopolymers that would help in extending this project are presented in the 
following paragraphs: 
 Biopolymers are polymers formed in nature during the growth cycles of all organisms. 
Hence, they are also referred as natural or biological polymers. Their synthesis involves 
enzyme catalyzed chain growth polymerization reactions of activated monomers, which 
are generally formed within the cells by complex metabolic processes. The most 
prevalent structural biopolymers are the polysaccharide cellulose in higher plants and 
protein collagen in animals, but several other rare polymers exist in nature, which serve 
these roles and are of particular interest for material applications. Some of the important 
biological materials are:  
Collagens- they are structurally related proteins, which occur in all animals and are most 
abundant proteins in vertebrates. They are extra-cellular proteins that are organized into 
insoluble fibers of great strength. Collagens provide the insoluble scaffold for the 
provision of shape and form. Collagens occur as super molecular assemblies, with the 
attachment of macromolecules, glycoproteins hydrated polymers, inorganic ions and 
cells. The range in morphology is from rope-like fibrils that provide the fibrous scaffold 
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maintaining the integrity of tendons, ligaments, bone and teeth to net like sheets in the 
basement membranes that underline epithelial and endothelial cells.  
Elastin-is a structural protein found in a relatively large amount in elastic yellow 
connective tissue that occur in ligaments, lung, aortic wall and skin. It is a protein with 
rubber like elastic properties whose fibers can stretch to several times their normal length. 
Unlike collagen, elastin does not have a secondary structure and has microfibrillar 
proteins that form the outer core of elastic fibers.  
Mucopolysaccharides - also called glycosaminoglycans, it is the substance around 
structural proteins. They bind to water and cations and exist in physiological conditions 
as viscoelastic gels. Therefore, solutions of glycosaminoglycans have slimy, mucus like 
constituency. They are all linearly polymerized without branching. Hyaluronic acid and 
chondrotin sulfates are most commonly found types of mucopolysaccharides. 
Proteoglycans-proteins and glycosaminoglycans in ground substance aggregate 
covalently and non-covalently to form a diverse group of macromolecules known as 
proteoglycans. Proteoglycans subunits consist of a core protein to which 
glycosaminoglycans, most often keratin sulfate and chondrotin sulfate, are covalently 
linked.  
Cellulose and its derivatives- Cellulose, the primary structural component of plant cell 
walls, account for over one half of carbon in biosphere. It is a linear polymer consisting 
of D-glucose residues linked by beta 1-4 glycoside bonds. This highly cohesive hydrogen 
bonded structure gives cellulose fibers exceptional strength and makes them water 
insoluble. All the important derivatives of cellulose are reaction products of one or more 
of the three-hydroxyl groups, which are present in each glucopyranoside, repeating units. 
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These derivatives are (a) ethers-methyl cellulose, hydroxyethyl cellulose (b) esters-
cellulose acetate, cellulose xanthate, which is used as a soluble intermediate for 
processing of cellulose into either fiber or film forms during which the cellulose is 
regenerated by controlled hydrolysis and (c) acetals-cyclic acetals formed between 
hydroxyl groups and butyraldehyde.  
Chitin- is water insoluble cellulose like biopolymer consisting of linear beta 1-4 N-acetyl-
D-glucosamine. It is not found in vertebrates and plants, but in insects, crustaceans and 
microbes. Chitosan which is a deacetylated chitin is used as food additive. Chitosan 
albumin microspheres were prepared to deliver anti-tumor cisplatin (Nishihoka et al 
1989). Non-woven fabrics made of fibers of either chitin or chitosan were recently 
developed for use of wound dressing. Regenerated chitin once applied to a wound is 
slowly hydrolyzed and disappears after 3 months.  
Other biopolymers, which find their applications as biomaterials are dextrans, alginates, 
pectins, gums and agar agar. 
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Abstract 
     Doubled wall microspheres are required especially 
when a better encapsulation efficiency and controlled 
release is necessary. In this study, we will present the 
fabrication and characterization of double walled 
microspheres by exploring the solubility and insolubility 
of polymers in different solvents. 
 
Introduction 
     Poly lactide-co-glycolide (PLGA50:50) is soluble in 
both dichloromethane(DCM) and ethyl acetate (EA) 
whereas poly lactide (PLLA) is soluble only in DCM. 
This property of PLLA is utilized in order to fabricate 
doubled walled microspheres. When PLLA solution in 
DCM is poured into PLGA solution in EA, then a PLLA 
inner core and PLGA outer cover can be prepared. The 
fabrication and characterization will be presented 
 
Experimental Method 
     A solvent evaporation method is used for the 
fabrication of double walled microspheres. Briefly, 
100mg of PLLA is dissolved in DCM and 12mg of 
Gentamicin as solid is suspended in it by ultrasonication. 
200mg of PLGA is dissolved in EA (see Table 1 for 
composition). Three compositions as described in the 
table are fabricated. PLLA-GS solution is poured into 
ethyl acetate containing PLGA and ultrasonicated again. 
This mixture is poured into 500ml of 2% poly vinyl 
alcohol (PVA) and stirred at 400rpm for 4 hours. The 
microspheres formed were filtered washed and dried. 
 
     The composition of core and shell polymer is analyzed 
using Fourier Transform Infrared Spectroscopy (FTIR)-
microscope. Cross sectioning of the microspheres is done 
using a freeze microtome and SEM is used to get the 
micrographs. Gentamicin is analyzed using a  
high-pressure liquid chromatography (HPLC) after 
derivatization with o-phthalaldehyde reagent.  
 
Results and Discussion 
     When higher concentration of PLLA (consider as A) is 
poured into a lower concentration of PLGA (consider as 
B), then drops of A will be formed and around which B 
will be distributed. During the hardening of micro 
spheres, it was observed that, at the instant the drop is 
formed, the drop of B is still not hardened and is soft. 
Then DCM in it tries to migrate radially outside and 
hardening first occurs at the interface of PLLA (inside) 
and PLGA (outside). Now, at the interface, PLLA is 
totally solid and PLGA is in dissolved state in EA. Still 
DCM tries to come out radially in the outward direction 
and EA tries to go inside. Along the path which EA 
travels, PLLA will solidify from outside to inside. Along 
the path of DCM, PLLA tries to go outside from inside. A 
stage reaches where the core has only EA, for 
concentration balance with outside EA and DCM diffused 
mostly into outside EA. At this stage, PLLA is entirely 
solidified inside and PLGA is in dissolved state on the 
outside. When this is poured into water phase both EA 
and DCM will diffuse out leaving a crater inside. Since 
this explanation might be an ideal situation, we might see 
PLLA diffusing a bit into outer cover, and PLGA 
diffusing a bit into inner core and hence overlapping of 
FTIR results.  
 
     It can be seen in SEM of A (Fig 1) that the surface has 
a largely porous structure. This may be possible due to the 
rapid escape of DCM/EA from inside to the outside of the 
microsphere. SEM of B (Fig 2) shows a relatively smooth 
surface, however a few pores can be observed and this 
also can be explained by the diffusion of solvent from 
inside to the outside. Surface SEM of C also looks similar 
and hence it is not shown. Cross-section SEM of C(Fig 3)  
shows a hole inside with a visible change in smoothness 
from inside to the outside. The FTIR results of samples B 
and C (Fig 4 and 5) against a blank PLGA and PLLA 
have shown the formation of a double wall structure. 
However, certain amount of PLGA can be seen in the 
core region and certain amount of PLLA can be seen in 
the shell region. This along with the FTIR results it is 




     We were able to prepare double wall microspheres and 
have observed that the encapsulation efficiencies can be 
achieved. However, further studies need to be carried out 
in order to increase the encapsulation efficiency. In vitro 








A 1 5 <3 
B 5 10 17.98+2.18 
C 5 15 26.8+2.06 
 
Table 1. Composition and encapsulation efficiency of 

















Figure 1. SEM of sample A 
 














Figure 2. SEM of sample B 
 
 





















































Figure 5. FTIR of sample C 
 
NOTE: In figure 4 and 5, the representation is as follows: 
1-PLGA, 2-Shell, 3-PLLA and 4-Core. The wave number 
is from 1300 cm-1 to 1500 cm-1 in increments of 20 cm-1. 
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     Osteomyelitis is one of the major bone diseases 
and successful treatment involves local 
administration of Gentamicin for long periods of 
time. Spray drying is employed to obtain 
microspheres and in vitro release is studied for 
microspheres, discs made by compressing 
microspheres and modified discs obtained by the use 
of additives.  
 
Introduction 
     Treatment is currently being achieved by the 
local administration of polymethyl methyacrylate 
(PMMA) loaded with Gentamicin. However, the use 
of PMMA has some disadvantages. PMMA is not 
degradable and not compatible and a second surgery 
is required to remove it. It supports bacterial growth 
and triggers inflammatory responses and in many 
cases there is residual drug in PMMA. Hence, the 
use of biodegradable and bioresorbable materials 
loaded with Gentamicin is of interest. In the current 
study, the possibility of developing a formulation 
that can give sustained release for a period of 6 
weeks is investigated. The fabrication, 
characterization and in vitro release of Gentamicin 
from microspheres made of different poly lactide-co-
glycolide (PLGA) copolymers and discs made by 
compressing microspheres were studied. Also, poly 
ethylene glycol (PEG) was added to PLGA so as to 
modify the microsphere properties anticipating 
better release profiles. Tri-calcium phosphate and 
Hydroxylapatite were also used to modify the 
porosity of the discs. 
 
Experimental Methods 
     Spray drying is used to make microspheres and 
discs are obtained by compressing in a 5 mm 
evacuable die. Particle size analyzer is used to 
measure the particle size. Release of Gentamicin is 
studied in PBS buffer at pH 7.4 and 37C. Analysis 
of Gentamicin is done using high-pressure liquid 




Results and Discussion 
     Microspheres obtained by spray drying of PLGA 
50:50, PLGA 65:35 and PLGA 85:15 were in the 
size range of 1-2um. The encapsulation efficiency 
was between 50 and 65 % (Table 1). It was observed 
in scanning electron microscope (SEM) pictures (not 
shown) that there was agglomeration and 
deformation in shape of microspheres with 
increasing glycolic content, which can be attributed 
to the crystallinity of the polymers. All the 
microspheres released Gentamicin in less than a day. 
In order to extend the release time, the microspheres 
were compressed into discs with diameter of 5mm 
and the thickness was about 1mm. PLGA 50:50 was 
selected for making discs as it is known to degrade 
faster than the other copolymers. The discs made 
from only microspheres have shown a biphasic 
behavior which consisted of an initial release during 
the first day which corresponds to the release of drug 
from the surface, a lag phase for a period of up to 
approximately 25 days and a second release which 
starts approximately between 25-30 days, which 
corresponds to the bulk degradation of the polymer. 
The release was observed for another 25 days from 
this point. PEG was used as an additive to PLGA 
before spray drying and effect of molecular weight 
and PEG content was investigated. It was observed 
that PEG had the effect of increasing the initial 
release and the second release started earlier than 
pure PLGA 50:50 and lasted for lesser time (Fig. 1). 
The SEM pictures (Fig 2) show that the disc was 
porous initially corresponding to the initial release. 
It was observed that the disc expands in size after 
about 15 days corresponding to the rapid escape of 
PEG from the disc and the same can be observed in 
the SEM picture. The release from ceramic blended 
microsphere discs have shown a fast release or a 
slow release or a biphasic release depending on 
microspheres to ceramic ratio. An optimum amount 
of ceramic gave a 12-day release. Tri-calcium 
phosphate is easier to compress than hydroxylapatite 
and this is reflected in the irregular release profile 
from hydroxylapatite discs. Effect of two types of 




     It is possible to compress the microspheres in 
order to control the release of Gentamicin. The 
biphasic behavior of discs can be modified by the 
use of additives so that an appropriate release profile 
is achieved. PEG modified discs also gave a biphasic 
behavior and the discs modified using ceramics gave 
better release results.  
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Table 1. Encapsulation efficiency and particle size 

















Figure 1. In vitro release from pure PLGA 50:50 
disc and PEG modified discs. (In P10-8k, P10 
represents 10% PEG and 8k represents the Mol. Wt. 







Figure 2. SEM pictures of PLGA 50:50 and 10% 
PEG disc before in vitro release (a) and 20 days of in 
vitro release (b). 
 
 
Figure 3. In vitro release from ceramic modified 
discs. (M-microspheres, T-tri-calcium phosphate, H-
hydroxylapatite, the number represents the 
respective percentage of the component in disc) 
Mass of disc is 50mg. 
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DOUBLE WALLED MICROSPHERES 
 
As it was observed that the microspheres released all of the Gentamicin in less than a 
day, the work was directed towards the fabrication of a double walled microspheres, 
where the drug largely remains in an inner core protected by an outer cover of a second 
type of polymer that acts as a release rate-controlling layer. Doubled wall microspheres 
are required especially when a better encapsulation efficiency and controlled release is 
necessary (Wang 2001). 
 
Poly lactide-co-glycolide (PLGA50:50) is soluble in both dichloromethane(DCM) and ethyl acetate (EA) 
whereas poly lactide (PLLA) is soluble only in DCM. This property of PLLA is utilized in order to 
fabricate doubled walled microspheres. When PLLA solution in DCM is poured into PLGA solution in EA, 
then a PLLA inner core and PLGA outer cover can be prepared. Briefly, A solvent evaporation method is 
used for the fabrication of double walled microspheres. Briefly, 100mg of PLLA is dissolved in DCM and 
12mg of Gentamicin as solid is suspended in it by ultrasonication. 200mg of PLGA is dissolved in EA. 
Three compositions as described in the table are fabricated. PLLA-GS solution is poured into ethyl acetate 
containing PLGA and ultrasonicated again. This mixture is poured into 500ml of 2% poly vinyl alcohol 
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Table A.1 Inner is PLLA (in DCM); outer is PLGA (in EA). EE is encapsulation 
efficiency.                                          
 
Sample Name Type of PLGA 
coating to 
PLLA 
Inner % Outer % E.E %  
A PLGA 85:15 1 5 <3 
B PLGA 65:35 1 5 <3 
C PLGA 50:50 1  5 <3 
D PLGA 50:50 5 10 17.98 + 2.18 
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Fig. A.1 A, B, C, D and E. The SEM figures showing the porosity when different 
concentrations of the polymer solutions are used.   
 
These samples are then passed on to the Final Year Project Student Ms. Magdeleine Duan Ning Lew for 
further studies like in vitro and analyzing the cross section. Also, since the above-mentioned procedure 
gives small size microspheres, it was planned for her project to use the property of phase separation in 
single solvent when the concentration of polymers is high so that we can get similar larger microspheres. 
The combined results and discussion are presented in as Naraharisetti et al, 2003.
E 






Double walled microspheres were prepared based on the properties of the two polymers 
PLLA and PLGA in that PLGA is soluble in both dichloromethane and ethyl acetate 
whereas PLLA is soluble only in dichloromethane. Utilizing the same property of PLLA, 
the possibility of developing a delivery system, which resembles a sandwich in which, 
the bottom layer is made of PLLA, the top layer is PLGA with the drug in the middle 
Mauduit et al, 1993). 
 
PLLA solution in dichloromethane is poured into a petri-dish and the solution is left for 
dichloromethane to evaporate. In order to control the evaporation of dichloromethane the 
petri-dish is covered. It appears that uncontrolled evaporation lead to buckling of the 
PLLA layer. When PLLA forms a film, a suspension of Gentamicin in ethyl acetate is 
poured on to this layer and the ethyl acetate is allowed to evaporate. Later a solution of 
PLGA in ethyl acetate is poured on to this in order to fabricate a sandwich type of system 
where the drug rests in the middle. It appears that successful fabrication of such a system 
will allow the fabrication of a membranous delivery vehicle where controlling the 
thickness of the polymer layers can control the rate of drug release.  
 
However, PLLA does not appear to have enough strength to prepare a film that can 
withstand the vigor of post fabrication processes and also, the fabrication of a layer of 
PLLA was difficult as the material tends to buckle.  
